Title : Exploring the Benzazoles Derivatives as Pharmacophores for AChE, BACE1, and as Anti-Abeta Aggregation to Find Multitarget Compounds against Alzheimer's Disease - Rosales_2024_Molecules_29_ |
Author(s) : Rosales Hernandez MC , Olvera-Valdez M , Velazquez Toledano J , Mendieta Wejebe JE , Fragoso Morales LG , Cruz A |
Ref : Molecules , 29 : , 2024 |
Abstract :
Despite the great effort that has gone into developing new molecules as multitarget compounds to treat Alzheimer's disease (AD), none of these have been approved to treat this disease. Therefore, it will be interesting to determine whether benzazoles such as benzimidazole, benzoxazole, and benzothiazole, employed as pharmacophores, could act as multitarget drugs. AD is a multifactorial disease in which several pharmacological targets have been identified-some are involved with amyloid beta (Abeta) production, such as beta secretase (BACE1) and beta amyloid aggregation, while others are involved with the cholinergic system as acetylcholinesterase (AChE) and butirylcholinesterase (BChE) and nicotinic and muscarinic receptors, as well as the hyperphosphorylation of microtubule-associated protein (tau). In this review, we describe the in silico and in vitro evaluation of benzazoles on three important targets in AD: AChE, BACE1, and Abeta. Benzothiazoles and benzimidazoles could be the best benzazoles to act as multitarget drugs for AD because they have been widely evaluated as AChE inhibitors, forming Pi-Pi interactions with W286, W86, Y72, and F338, as well as in the AChE gorge and catalytic site. In addition, the sulfur atom from benzothiazol interacts with S286 and the aromatic ring from W84, with these compounds having an IC(50) value in the microM range. Also, benzimidazoles and benzothiazoles can inhibit Abeta aggregation. However, even though benzazoles have not been widely evaluated on BACE1, benzimidazoles evaluated in vitro showed an IC(50) value in the nM range. Therefore, important chemical modifications could be considered to improve multitarget benzazoles' activity, such as substitutions in the aromatic ring with electron withdrawal at position five, or a linker 3 or 4 carbons in length, which would allow for better interaction with targets. |
PubMedSearch : Rosales_2024_Molecules_29_ |
PubMedID: 39407708 |
Rosales Hernandez MC, Olvera-Valdez M, Velazquez Toledano J, Mendieta Wejebe JE, Fragoso Morales LG, Cruz A (2024)
Exploring the Benzazoles Derivatives as Pharmacophores for AChE, BACE1, and as Anti-Abeta Aggregation to Find Multitarget Compounds against Alzheimer's Disease
Molecules
29 :
Rosales Hernandez MC, Olvera-Valdez M, Velazquez Toledano J, Mendieta Wejebe JE, Fragoso Morales LG, Cruz A (2024)
Molecules
29 :